The global market for weight management solutions continues to expand, driven by increasing awareness of obesity-related health issues and a desire for effective interventions. Within this dynamic market, pharmaceutical intermediates like Orlistat play a pivotal role. Orlistat, with its unique mechanism of action as a lipase inhibitor, is a cornerstone ingredient for many anti-obesity medications and dietary supplements. Its ability to prevent the absorption of dietary fats directly addresses a key factor contributing to weight gain, making it a highly sought-after compound for formulators and manufacturers in the health and wellness sector.

As a pharmaceutical intermediate, the quality and consistency of Orlistat are paramount. Manufacturers rely on suppliers who can provide material that meets stringent purity standards, typically exceeding 99%. The CAS number 96829-58-2 serves as a critical identifier for sourcing and regulatory compliance. The physical characteristics of Orlistat, such as its white crystalline powder appearance, are also important indicators of quality and proper processing. The molecular formula C29H53NO5 and its molecular weight, along with its EINECS number, are vital pieces of information for chemists and quality control professionals to verify the identity and integrity of the substance.

The supply chain for pharmaceutical intermediates is complex, requiring reliable partnerships. Companies like NINGBO INNO PHARMCHEM CO.,LTD. are instrumental in ensuring that manufacturers have access to high-grade Orlistat. Their ability to provide comprehensive product information, including COAs and MSDS, and to manage logistics efficiently, is crucial for maintaining production schedules and meeting market demand. As the weight loss market continues to evolve, the demand for effective and safely produced pharmaceutical ingredients like Orlistat is expected to remain robust, making a strong supplier relationship a strategic advantage for any company operating in this space.